The Digital Fertility Support Market, currently valued at USD 1.5 billion in 2021, is projected to reach USD 2.2 billion by 2030, growing at a CAGR of 8.5% during the forecast period from 2023 to 2030.
Factors driving the growth of the market include the increasing use of mobile applications for fertility tracking, rising awareness about fertility and fertility-related issues, and the growing prevalence of conditions such as polycystic ovary syndrome (PCOS) and endometriosis.
It’s important to note that these projections are subject to change based on various factors such as global economic conditions, technological advancements, and changes in government policies.
The growth of this market is attributed to various factors including a decline in fertility rates, an increase in the number of fertility clinics worldwide, technological advancements, and rising public-private investments, funding, and grants. .
Digital fertility support solutions offer services to help treat infertility, which can affect both males and females of childbearing age due to various factors like alcohol and drug consumption, stress, smoking, obesity, environmental factors, and sedentary lifestyles.
The COVID-19 pandemic has posed a significant threat to the global fertility treatment industry, with logistical concerns, treating patients with the disease, prioritizing patients with comorbidities and pre-existing disorders, and safeguarding being some of the key obstacles faced by healthcare systems worldwide.
In order to stay competitive in the market, companies are adopting various strategies like mergers and acquisitions, partnerships, and launching new products to contribute significantly to market growth.
Read More : https://virtuemarketresearch.com/report/digital-fertility-support-market
Some of the major players operating in the digital fertility support market are:
- Esco Micro Pte. Ltd
- Ferring B.V.
- FUJIFILM Irvine Scientific
- Genea Limited
- Hamilton Thorne, Inc
- Ihmedical A/S
- INVO Bioscience
- IVFTech Aps
- Kitazato Corporation
- LABOTECT GMBH
- Medgyn Products, Inc
- Merck KGaA
- Rocket Medical PLC
- Somatex Medical Technologies GmbH
- Thermo Fisher Scientific
- Vitrolife AB
- ZEISS International